Bayer reaches Roundup settlement that could cost the company billions
In brief
The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma – a blood cancer linked to the herbicide.
This is a summary provided by NPR News. Read the complete story on the publisher’s website.
Continue reading at NPR News ↗
